Global prevalence and risk factors of suicidality among head and neck cancer patients—systematic review and meta-analysis
Supportive Care in Cancer · 2025
DOI: 10.1007/s00520-025-09244-9 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Supportive Care in Cancer, 2025. Verfasst von Shivani Sharma und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Louisiana State University Health Sciences Center, Shreveport, LA, USA. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Suicide, Suicidal Ideation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 68 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
PURPOSE: Suicidality is a pertinent issue among head and neck cancer patients. Our primary aim is to investigate the current suicidality rate among head and neck cancer (HNC) patients and evaluate risk factors associated with suicidality. METHODS: We thoroughly searched primary original research from January 2024 onwards across several databases, including PubMed, Embase, ScienceDirect, Web of Science, Scopus, and PsycINFO. Using a random-effects model, we calculated the odds ratio (OR) for risk factors and conducted a proportional meta-analysis to estimate prevalence and 95% confidence intervals (CI). RESULTS: Out of 15 included studies, 305,146 head and neck cancer patients were included. The global prevalence of suicidality among head and neck cancer patients was estimated at 6.8% (95% CI 2.0-20.6%). Major depressive disorder (RR = 5.13, 95% CI 3.60-7.30), psychiatric disorders (RR = 3.73, 95% CI 2.65-5.25), alcohol abuse (RR = 2.67, 95% CI 1.71-4.16), substance abuse (RR = 2.47, 95% CI 1.58-3.85), smoking/nicotine dependence (RR = 2.03, 95% CI 1.60-2.58), and functional compromise (RR = 1.74, 95% CI 1.29-2.36) were identified as significant risk factors. Subgroup analysis by geographical location revealed variations in prevalence, with Asia reporting lower rates than Europe and North America. CONCLUSION: This systematic review reports the current suicidality rate associated with head and neck cancer patients. Major depressive disorder and other psychiatric comorbidities pose substantial risks requiring early intervention in mitigating the burden of suicidality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Louisiana State University Health Sciences Center, Shreveport, LA, USA.
- Department of Otolaryngology-Head and Neck Surgery, Louisiana State University Health Sciences Center, 1501 Kings Highway, Shreveport, LA, 71103, USA.
- Louisiana State University Health School of Medicine, Shreveport, LA, USA.
- Department of Otolaryngology-Head and Neck Surgery, Louisiana State University Health Sciences Center, 1501 Kings Highway, Shreveport, LA, 71103, USA. cherieann.nathan@lsuhs.edu.
- Department of Surgery, Overton Brooks Veterans Administration Medical Center, Shreveport, LA, USA. cherieann.nathan@lsuhs.edu.
Zitieren
APA
Sharma, S., Vasudevan, S. S., Walker, N., Shimkus, G., Goyal, S., Pang, J., Beedupalli, K., & Nathan, C. O. (2025). Global prevalence and risk factors of suicidality among head and neck cancer patients—systematic review and meta-analysis. Supportive Care in Cancer. https://doi.org/10.1007/s00520-025-09244-9
Vancouver
Sharma S, Vasudevan SS, Walker N, Shimkus G, Goyal S, Pang J, et al. Global prevalence and risk factors of suicidality among head and neck cancer patients—systematic review and meta-analysis. Supportive Care in Cancer. 2025. doi:10.1007/s00520-025-09244-9
BibTeX
@article{Sharma2025,
author = {Sharma, Shivani and Vasudevan, Srivatsa Surya and Walker, Nakoma and Shimkus, Gaelen and Goyal, Shriya and Pang, John and Beedupalli, Kavitha and Nathan, Cherie-Ann O},
title = {Global prevalence and risk factors of suicidality among head and neck cancer patients—systematic review and meta-analysis},
journal = {Supportive Care in Cancer},
year = {2025},
doi = {10.1007/s00520-025-09244-9}
}
EUVIMED